GLPGF vs REGN: Which Stock is Better?
Side-by-side comparison of Galapagos Nv and Regeneron Pharmaceuticals Inc in 2026
GLPGF
Galapagos Nv
$33.27
REGN
Regeneron Pharmaceuticals Inc
$749.41
Key Metrics Comparison
| Metric | GLPGF | REGN | Winner |
|---|---|---|---|
| Market Cap | $3.21B | $79.35B | REGN |
| P/E Ratio | 8.56 | 18.08 | GLPGF |
| EPS (TTM) | $5.69 | $41.51 | REGN |
| Revenue Growth | 10.9% | 0.0% | GLPGF |
| Gross Margin | 56.0% | 44.6% | GLPGF |
Analyze GLPGF
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GLPGF or REGN a better investment?
Comparing GLPGF and REGN: Galapagos Nv has a market cap of $3.21B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GLPGF and REGN?
GLPGF (Galapagos Nv) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GLPGF or REGN?
Based on P/E ratios, GLPGF trades at a lower multiple (8.6x vs 18.1x).
Which is growing faster: GLPGF or REGN?
GLPGF has higher revenue growth at 10.9% vs 0.0% for REGN.
Which company is more profitable: GLPGF or REGN?
Galapagos Nv (GLPGF) has higher gross margins at 56.0% compared to 44.6% for REGN.
Which is the larger company: GLPGF or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $3.21B for GLPGF.
Should I buy GLPGF or REGN in 2026?
Both GLPGF and REGN have investment merit. GLPGF trades at $33.27 while REGN trades at $749.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GLPGF and REGN stock?
Key differences: Market Cap ($3.21B vs $79.35B), P/E Ratio (8.6x vs 18.1x), Revenue Growth (10.9% vs 0.0%), Gross Margin (56.0% vs 44.6%).